Science News

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. and Epis NexLab Co., Ltd., a sister company to Samsung Bioepis under Samsung Epis Holdings (KRX: 0126Z0), today announced a research collaboration and license agreement with G2GBIO, a company specializing in the development of sustained-release formulations, to develop novel assets based on G2GBIO’s proprietary microsphere technology. Under the agreement, Samsung Bioepis will be given a full license right for the novel long-acting semag...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

MINNEAPOLIS--(BUSINESS WIRE)--Pivot Bio, one of the world's leading innovative agtech companies, will be taking the stage at the World Agri-Tech Innovation Summit taking place March 16–18, 2026. Chris Abbott, chief executive officer, will participate in a fireside chat titled “Capturing Innovation in a Transformed Agri-Food Landscape” on the Main Stage on March 17 at 4:15 p.m. PT. Abbott will be joined by Scott H. Hutchins, Under Secretary for Research, Education, and Economics & Chief Scie...

PHILADELPHIA--(BUSINESS WIRE)--GSK’s RSV vaccine, AREXVY, approved in US for expanded age indication in adults aged 18–49 years at increased risk...

BERKELEY, Calif.--(BUSINESS WIRE)--We are enabling validation and rapid iteration so researchers can turn cofolding models into scientific infrastructure that speeds drug discovery...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC (“Ignite”), a commercial-stage precision oncology company focused on addressing a critical challenge in cancer care: optimizing therapy selection. Ignite’s functional proteomics platform has demonstrated the ability to identify cancer therapy responses that may not be cap...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET. The presentation will be accessible via a live webcast on the Events and Presentations page in the Investo...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies reports financial results for FY 2025, including record revenue and unit sales for the CyPath Lung test for lung cancer....

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc., a clinical-stage pharmaceutical company developing innovative therapies for diabetes based on the breakthrough discovery of the role of TXNIP in disease progression, today announced the expansion of a program-related investment (PRI) made by The Leona M. and Harry B. Helmsley Charitable Trust in furtherance of their charitable purpose. The expanded PRI, in the form of a loan, provides TIXiMED with an additional $2.2 million to support the compan...

BLOOMINGTON, Minn.--(BUSINESS WIRE)--A commentary from HealthPartners Institute published in the Journal of Aging Research & Lifestyle points to a hidden cost of modern work. As jobs increasingly revolve around screens, long hours of sitting and constant connectivity, the brain systems that power memory, focus, creativity and emotional well-being are under strain. The commentary, written by Nico Pronk, PhD, president and chief science officer of HealthPartners Institute, describes a “sedent...